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"The desire to take medicine is one
feature which distinguishes man, the
animal, from his fellow creatures. It is
really one of the most serious difficulties
with which we have to contend."
Sir William Osler said this over 70 years
ago, and I repeat it to remind you that not
all the drugs ingested by patients have neces-
sarily heen prescribed by their physician. A
recent survey at a London hospital revealed
that 80 per cent. of patients admitted to medi-
cal and surgical wards during a one-month
period had treated themselves for various ail-
ments over the previous twelve months.
Adverse reactions to drugs may he defined
as those effects of a drug which may be in-
convenient or harmful to the patient and occur
in addition to its planned therapeutic effect.
These so-called adverse reactions are part of
the price society pays for the benefits gained
from advances in the medical treatment of
disease. To the individual concerned this is
a cold, hard fact which may be difficult to
accept with equanimity when suffering such a
reaction. However, if, when the drug was pre-
scribed, proper consideration was given to the
possible benefit to the patient as contrasted to
the known risks involved, then the problem
will not be a serious one, and the complica-
tions assessed as a 'calculated risk'.
In practice, wheI\ a drug is given the aim is
to achieve a specific therapeutic effect, for
example, aspirin for the relief of pain. Other
advantageous effects may also occur, sedation
and the lowering of fever, if this is present.
Unfortunately, at the same time, adverse reac-
tions may also occur, which may be minor or
serious.. With aspirin, dyspepsia or haemorr-
hage from a gastric or duodenal ulcer may
occur.
JReceived June, 1966.
Aust. J. Physiother., XIII, 1, March, 1967.
What are adverse reactions in some diseases
may be useful actions in other diseases. The
antiwdepressant drug imipramine, may cause
urinary retention in some depressed patients,
but this property is of value in the treatment
of enuresis in children.
In this discussion, undersirahle effects, side
effects, of a drug, which could he expected
from study of its pharmacological action, will
not be considered. I admit this may he a
semantic quibble, as at times these side effects
may he severe enough to constitute an adverse
reaction.
How can these reactions be prevented, or
at least minimized? The task begins when a
new compound is thought to have some valu~
able therapeutic potential.
The development of a new drug goes
through various stages. The first three are
not mutually exclusive hut may overlap at
times. The time interval from Stage I to Stage
IV may be as long as five to seven years.
Stage 1
Animal pharmacology and toxicity studies
following initial tests indicating new or useful
action.
Stage II
Human pharmacology and initial clinical
trials.
Stage III
Clinical trials with larger numbers of
patients still limited in scope and numbers.
Stage IV
Commercial release involving possible wide-
spread usage of the drug in many thousands
of patients.
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At every stage up to that of commercial
release, the data available is checked and
assessed by the manufacturer and the Federal
Government health authorities. Only when the
compound is assessed as safe and effective is
it released for general use.
However, it is impossible to predict all
potential hazards by the methods available in
the first three stages.. Rare or unusual reactions
may not be detected in the relatively small
numbers of patients treated in the clinical
trials. There is a great variation in the indi-
vidual's reaction to a drug, especially when
age, sex, nutrition, general standard of health,
and many other factors have to be taken into
account.
It is therefore necessary for large numbers
of many sections of the population to take a
drug before we can be sure of its relative
safety. The word "relative" is used advisedly;
absolute safety is as yet an unattained ideal.
Stage IV then must include a period of sur-
veillance and for some years close attention
should be given to any adverse reactions re-
ported associated with new drug therapy so
that a true picture of its safety in humans may
be obtained. Medical and paramedical workers
must he on the alert to detect possible adverse
reactions, firstly to protect the individual
patient from harm, and also to accumulate in-
formation which will give a true idea of a
drug's capacity to hurt as well as heal.
It is important to remember that as well
as harming the patient, a new drug (or an old
and well-established one for that matter) may
also maim or harm the embryo or foetus. For
this reason in general, no new drug should
be given to a pregnant woman, especially dur..
ing the first three months of pregnancy; in
fact it is advisable not to give new drugs to
women likely to become pregnant, though this
is obviously a counsel of perfection and not
always capable of achievement.
After a new drug has been in general use
for two years or more the situation can he
reassessed.
In Australia, a Drug Evaluation Committee
has heen set up under the Chairmanship of
Dr. Edgar Thomson. The Secretary to this
Committee is Dr. Bruce Royall, who is also
Director of the Therapeutic Substances Divi-
son of the Federal Health Department. An
adverse drug reaction reporting system has
been established so that doctors and dentists
may notify the Committee of any new or
serious drug reactions which may occur in
their practices. The importance and serious~
ness of these effects is assessed by the Com-
mittee, and appropriate action is then taken
either to warn the medical profession regard-
ing the hazards of the particular drug, or in
extreme cases, the compound may be banned
and withdrawn from use.
The co-operation between the Committee
and pharmaceutical manufacturers has been
excellent, and so far the system is working
extremely well.
Adverse reactions can he classified as being
due to intolerance, idiosyncrasy and allergy.
Drug intolerance means the expected effects
of the drug are produced by an unusually
small dose.
Drug idiosyncrasy means the patient reacts
to the drug in an unexpected manner.
Drug allergy means the patient becomes
sensitized to the drug and develops an allergic
type of reaction when the drug is administered.
Another cause of adverse reactions to drugs
is drug interaction. In this instance, the com-
bination of two or more drugs produces a
reaction which might have been expected from
either drug but to a more severe degree, or
alternatively, the combination produces new
and bizarre adverse reactions, not seen to
occur when the drugs are given singly.
In these days of polypharmacy when it is
not unusual for a patient to be taking at least
three to five potent compounds at the same
time, drug interaction is becoming more and
more important as a cause of adverse reactions.
In this context it is worth mentioning in pass-
ing that there may be interaction between a
drug and certain items of a patient's diet .. I
will refer to this again when I discuss specific
drug groups..
Before proceeding to a discussion of par-
ticular drug groups, I would like to make
some general comments on types of adverse
reactions which are commonly observed.
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Skin Reactions
Skin reactions may vary from mild to severe
urticaria or hives, through to severe exfoliative
dermatitis involving loss of large areas of
skin surface.
Blood Dyscrasias
Adverse reactions involving bone marrow
function can range from leucopenia or agranu-
locytosis through to aplastic anaemia where
production of all elements of the blood is
severely depressed. Blood platelet function
may be specifically disturbed resulting in pur-
puric rashes and haemorrhage.
Liver Disorders
Liver function may be disturbed, the first
sign of which may be jaundice. This, at times,
is very difficult to differentiate from viral
hepatitis.
Behavioural Toxity
A wide variety of disturbances of normal
behaviour may result from the use of many
drugs, particularly those used in the treatment
of psychiatric disorders, though these reactions
are not confined exclusively to that group.
The patient's judgement may be impaired,
hence they should not drive a motor car. They
may become over stimulated, or euphoric, or
alternatively, retarded and depressed. MU8CU~
lar co-ordination and control may be dis-
turbed and tolerance to alcohol greatly
diminished.
The reactions discussed do not include all
the possibilities, hut I have tried to lay em..
phasis on important reactions, particularly
those which may be suspected by observation
or from the patient's symptoms without any
detailed investigation.
I will now discuss, in some detail, the par-
ticular groups of drugs which I felt would be
of most interest to the members of your
Association.
DRUGS USED IN RHEUMATIC DISEASES
Salicylates may be taken in a number of
forms, most commonly as aspirin, soluble
aspirin or sodium salicylate. They may cause
dyspepsia, nausea and vomiting, gastro in-
testinal bleeding; in high doses, tinnitus and
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dizziness, and in susceptible individuals,
allergic reactions (1 in 500), such as rashes
and anaphylactic shock in rare instances. The
danger of these widely used remedies to young
children is not generally appreciated. In in-
fants, particularly under the age of twelve
months, apparently small doses may produce
serious, or even fatal effects.
Pyrazoles: Butazolidin (phenylbutazone)
and Tanderil (oxyphenbutazone).
These compounds are widely used because
of their potent anti-inflammatory action. They
may cause dyspepsia, gastro intestinal
haemorrhage, especially in patients with active
peptic ulceration, fluid retention, allergic
rashes, and in rare instances leucopenia, agra-
nulocytosis and aplastic anaemia. An associa..
tion of this drug with leukaemia has been
proposed by some writers. However, no statis-
tical or other evidence has yet been provided
to confirm this allegation ..
These compounds may also potentiate the
action of other drugs such as barbiturates and
anticoagulants.
Anti-malarials: Chloroquine and hydroxy~
chloroquine.
These compounds which, like all others in
the group under discussion, are employed for
their anti-inflammatory action, may cause skin
eruptions. Also, depending on the dosage and
duration of therapy, adverse effects on the
eye have been reported, which may he corneal,
with deposition of the drug in the cornea
which is reversible, or retinal changes which
may be permanent (incidence 0.1 to 15 per
cent., various authors). Close observation of
the patient is necessary to avoid or minimize
these complications.
Indomethacin: Indocid.
This is a newly-introduced anti-inflamma-
tory drug. The most common known adverse
reactions are severe headache, gastro intes~
tinal disturbance and haemorrhage, skin
rashes and behavioural disturbances such as
depression, anxiety and emotional disorders.
With the introduction of lower dosage regimes
and a capsule form instead of tablets, adverse
reactions appear to be less frequent than were
reported in the earlier clinical trials. Very
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widespread use is necessary before the full
spectrum of potential adverse effects can be
fully determined ~
Gold
The most common adverse reactions to gold
involve the skin and mucous membranes,
especially of the mouth~ Reactions vary from
erythema to exfoliative dermatitis. DevelopG
ment of a skin reaction is often preceded by
pruritus. Blood dyscrasias such as leucopenia,
agranulocytosis and aplastic anaemia, may
also occur, but are uncommon.
Adreno-Cortical Steroids
Greeted with all the enthusiasm due to the
discovery of a "wonder drug" and used for
some time with even greater enthusiasm, the
adreno-cortical steroids have only recently
found their true place in medicine. They are
very potent compounds with a wide variety
of effects on the physiology and biochemistry
of the body. Cortisone, hydrocortisone, pred-
nisone and betamethasone are probably well
known to you all, and the last two compounds
are very possibly the most popular in use
today.
Adverse reactions to steroids may be severe
and even fatal. Sudden withdrawal after con-
tinuous therapy for long periods may have
E,erious consequences because of the suppres-
sion of the production of natural steroids by
the adrenal cortex. Long-term therapy may
cause fluid and electrolyte disturbances, dia~
betes, lowered resistance to infection, peptic
ulcer, depressive psychosis, osteoporosis, and
the syndrome of "moon-face", "buffalo hump",
and obesity.
ANTI-HYPERTENSIVE DRUGS
Oral Non-Mercurial Diuretics
The thiazides and related diuretics all tend
to cause loss of potassium when exerting their
therapeutic role of eliminating excess salt and
water~ When the body potassium stores are
depleted, weakness, lassitude and cardiac ir-
regularities may occur. This potassium loss
may be serious, especially in patients on digi-
talis compounds, or in those suffering from
liver disease.
Other adverse effects may be glycosuria and
uric acid retention. This raised serum uric acid
can lead to the precipitation of acute gouty
attacks in susceptible individuals. In rare in-
stances~ blood dyscrasias have been reported,
e.g. agranulocytosis or thrombocytopenia.
Rauwolfia Compounds
Reserpine, the active principal of the rau-
wolfia drugs, acts as a sedative and mild
hypotensive agent. However, it may cause
severe mental depression leading to suicide
in some instances~ It may also cause gastric
haemorrhage or may reactivate peptic ulcera-
tion.
Guanethidine (Ismelin)
This is a potent drug which blocks the
release of noradrenaline from sympathetic
nerve endings. It is widely used. Ismelin may
cause postural hypertension, for example,
fainting or faintness when standing or after
exercise. Other adverse effects are diarrhoea,
pain over the parotid glands, nasal stuffiness,
muscular weakness and fluid retention.
Serious toxic effects are rare. Overdosage may
be troublesome because of the drug's pro-
longed action.
Methyldopa (Aldomet)
This widely used compound blocks synthesis
of noradrenaline and also serotonin. It is less
likely to cause postural hypertension than
guanethidine. Adverse effects are fairly com-
mon: drowsiness, mental depression, diarrhoea
and more rarely, nightmares and impotence.
PSYCHOTROPIC DRUGS
Because of the diversity and multiplicity of
compounds in this group, only some of the
major ones can be discussed.
Minor Tranquillisers, or Anti-Anxiety Drugs
Meprobamate (Miltown) chlordiazepoxide
(Lihrium) and diazepam (Valium) and of
course the barbiturates, phenobarbitone,
amyloharbitone and so Oll, are the most widely
used agents. These compounds, especially the
first three, may cause adverse behavioural
effects such as impaired judgement or a feeling
of euphoria which may make motor driving, or
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any other skilled task, much more hazardous.
Miller (1962) has shown that 60 patients on
one of these drugs over a 90 w day period had
ten times more accidents than would have been
predicted from the normal population. Habi..
tuation and withdrawal syndrome on sudden
cessation of therapy has also been reported.
Ataxia and muscular incowordination may also
occur.
Major Tranquilizers, or AntiwPsychotic Drugs
The phenothiazine series, of which chlor..
promazine (Largactil) was the first to be
widely used, are the main members of this
group, though there have been newer develop..
ments with different chemical structure having
similar therapeutic actions, for example, Halo..
peridol, a butaphenone derivative. Central
nervous system reactions are important, and
may show up in three ways:
(a) by a syndrome resembling paralysis
agitans (Parkinson's disease) ;
(b) as uncontrolled restlessness or aka..
thesia;
(c) as various dystonic syndromes resem-
bling, for example, spastic torticollis.
Allergic reactions and liver dysfunction with
jaundice may also occur. Blood dyscrasias
have been reported, the frequency being more
related to the large amounts of these drugs
prescribed than to any special toxicity. Ad-
verse behavioural reactions are not usually a
great problem, particularly as patients on large
doses are usually in hospital.
AntiwDepressant Drugs
(a ) Monoamine oxidase inhibitors - these
compounds inhibit the enzyme monoa..
mine oxidase which is concerned with
the metabolism of the catecholamines
adrenalin, noradrenaline and serotonin.
The most commonly used in this
country are Parnate (tranylcypromine),
Marplan and Marsilid.
(b) Tricyclic anti-depressants-imipramine
(Tofranil) amitryptiline (Tryptanol and
Laryxol) .
With both the ahove groups adverse hew
havioural effects such as increased anxiety,
insomnia and aggravation of psychoses, have
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heen reported. Allergic reactions may occur.
Liver dysfunction and blood dyscrasias also
have been reported in rare instances. Hypo-
tension, urinary retention, and paralytic ileus
(rarely) have been reported.
Combination of monoamine oxidase in..
hibitors and the tricyclic compounds may
cause adverse central nervous system effects
such as restlessness, muscular twitching, con-
vulsions, hyperpyrexia and even death. Certain
foods and beverages, such as cheese, beer
and wine containing tyramine, when taken by
patients on monoamine oxidase inhibitors may
precipitate dangerous hypertensive episodes.
This association is now well documented and
patients should be warned of the hazard. There
are also a number of milder adverse effects,
many of which disappear with continuance of
therapy.
ANTIBIOTICS
Penicillin
Though virtually non-toxic in the general
sense, penicillin is the main cause of allergic
reactions which may vary from mild urticaria
to angioneuritic oedema to collapse and sudden
death. Once a patient is sensitized he must be
assumed to be 80 for all time, and should never
again be given penicillin in any form.
Broad Spectrum Antibiotics: chloramphenicol
and the tetracyclines
Severe diarrhoea may result, particularly
from the tetracyclines when given by mouth.
This is associated with the elimination of the
normal bowel bacterial flora, and may be
complicated by super infection with a resistant
strain of staphylococcus.
Chloramphenicol has been associated with
bone marrow damage and aplastic anaemia
may result. The incidence of this often fatal
reaction is not definitely known, but has been
estimated to be in the region of 1 in 60,000
(Witts, 1965). Allergic reactions to many of
the antibiotics have been reported though the
incidence varies from compound to compound.
Streptomycin is possibly the most likely to
cause skin reactions. The deposition of tetra..
cyclines in the teeth of infants producing a
yellow discolouration, has been reported, the
drug having been administered during the
mother's pregnancy.
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DISCUSSION
Having provided a formidable list of pos-
sible adverse reactions with a hint to many
not described, it is now essential to get the
problem into its proper perspective.
As well as thinking of the risk involved
in giving a particular drug, consideration
must always be given also to the risk of not
giving it Herein lies the dilemma facing the
physician. To make the right decision he must
know the drugs he uses as thoroughly as the
diseases he treats. Obviously the problem has
not been completely solved, as evidenced by
many comments, such as one made at The
American Medical Association Clinical Con-
vention in 1965: "Nowhere have the problems
involved in selection of a therapeutic agent
been more apparent than in the chronic rheu-
matoid disorders". Frew (1965) has estimated
that 10-15% of patients in hospital are suffer-
ing from iatrogenic disease, that is, disease
caused by treatment, which obviously in many
cases involves drugs. To balance the picture
we have the thoughts expressed by Professor
Witts: "Indeed the risks of modern drugs are
small in comparison with those of the motor
car and the cigarette", and "we are setting the
pharmaceutical industry a hard task when we
ask it to produce drugs which are effective
against serious diseases and yet non-toxic""
The solution of the problem lies in the
hands of the manufacturers, the Government
authorities and the medical profession.
Thorough and extensive investigation of drug
action by the manufacturer, close control and
scrutiny of drug action and adverse reaction
by the Government authorities and first-hand
knowledge by physicians of the drugs they use,
can all combine to reduce the element of risk
to the lowest possible figure.
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